Silva, S.; Cavaco, A.; Basso, B.; Mota, J.; Cruz-Duarte, R.; Costa, M.; Carvalho, L.; Lima, A.; Costa, L.; Ferreira, R.;
et al. Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression. Cancers 2022, 14, 6182.
https://doi.org/10.3390/cancers14246182
AMA Style
Silva S, Cavaco A, Basso B, Mota J, Cruz-Duarte R, Costa M, Carvalho L, Lima A, Costa L, Ferreira R,
et al. Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression. Cancers. 2022; 14(24):6182.
https://doi.org/10.3390/cancers14246182
Chicago/Turabian Style
Silva, Sara, Ana Cavaco, Bianca Basso, Joana Mota, Raquel Cruz-Duarte, Miguel Costa, Lara Carvalho, Ana Lima, Luis Costa, Ricardo Ferreira,
and et al. 2022. "Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression" Cancers 14, no. 24: 6182.
https://doi.org/10.3390/cancers14246182
APA Style
Silva, S., Cavaco, A., Basso, B., Mota, J., Cruz-Duarte, R., Costa, M., Carvalho, L., Lima, A., Costa, L., Ferreira, R., & Martins, M.
(2022). Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression. Cancers, 14(24), 6182.
https://doi.org/10.3390/cancers14246182